Croft, RJ; Mackay, AJ; Mills, AT; Gruzelier, JG; (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology (Berl) , 153 (3) 373 - 379.
Full text not available from this repository.
(+/-)-3,4-methylenedioxymethamphet-amine (MDMA; 'ecstasy'), a commonly used recreational drug, has typically been found to be related to poor cognitive function in humans. However, cannabis consumption may not have been adequately controlled for in these studies.
|Title:||The relative contributions of ecstasy and cannabis to cognitive impairment.|
|Keywords:||Adolescent, Adult, Analysis of Variance, Cognition, Cognition Disorders, Female, Hallucinogens, Humans, Male, Memory, N-Methyl-3,4-methylenedioxyamphetamine, Neuropsychological Tests, Tetrahydrocannabinol|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)|
Archive Staff Only: edit this record